Product image of Levetiracetam Ratiopharm (Levetiracetam) supplied by GNH India

Levetiracetam Ratiopharm

Active Ingredient:
Levetiracetam
Origin:
EU

Levetiracetam Ratiopharm (Levetiracetam)

Levetiracetam, the active ingredient in Levetiracetam Ratiopharm, is an anticonvulsant presented as an oral tablet for oral use. It is indicated for the treatment of partial seizures, generalized tonic‑clonic seizures, and myoclonic seizures, helping to reduce seizure frequency in individuals diagnosed with epilepsy.

GNH India supplies Levetiracetam Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics across global markets while adhering to stringent quality and regulatory standards. Our distribution network ensures reliable delivery and compliance with local import requirements.

Manufacturer / TM Owner

Ratiopharm Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levetiracetam is an anticonvulsant used to manage seizure disorders within the epileptic disease spectrum.

  • Partial seizures: Reduces frequency of focal onset seizures in patients with epilepsy.
  • Generalized tonic‑clonic seizures: Controls bilateral convulsive episodes and lowers recurrence.
  • Myoclonic seizures: Diminishes rapid, brief muscle jerks associated with myoclonic epilepsy.

How It Works

  • Levetiracetam binds to the synaptic vesicle protein SV2A, a key regulator of neurotransmitter release. This interaction modulates calcium‑dependent exocytosis, stabilizing neuronal membranes and decreasing hyper‑excitability. By reducing the release of excitatory neurotransmitters, the drug helps prevent the synchronized neuronal firing that underlies epileptic seizures.

Side Effects

Levetiracetam may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects

  • Dizziness: sensation of light‑headedness or unsteadiness.
  • Fatigue: feeling unusually tired or low in energy.
  • Headache: mild to moderate cranial pain.
  • Irritability: increased emotional sensitivity or agitation.
  • Nausea: upset stomach or urge to vomit.
  • Nasal congestion: blocked or runny nose.

Serious or Rare Side Effects

  • Severe allergic reaction: rash, swelling, or difficulty breathing.
  • Mood changes: depression, suicidal thoughts, or severe anxiety.
  • Blood disorders: thrombocytopenia or leukopenia.
  • Hepatic dysfunction: elevated liver enzymes or jaundice.
  • Multiorgan hypersensitivity: systemic rash with fever and organ involvement.

Precautions & Warnings

When prescribing Levetiracetam, clinicians should consider several safety considerations to minimize risk.

  • Renal function: Adjust dose in patients with impaired kidney function.
  • Psychiatric history: Monitor for mood alterations or suicidal ideation.
  • Concomitant CNS depressants: Use caution with other sedating agents.
  • Pregnancy status: Evaluate risk‑benefit as safety data are limited.
  • Driving and operating machinery: Advise patients about possible dizziness or drowsiness.
  • Store at ambient temperature: Keep tablets in the original container, protect from moisture and light.

Avoid Interactions

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • Carbamazepine: May reduce levetiracetam plasma levels, decreasing seizure control.
  • Phenobarbital: Potential to lower levetiracetam concentrations, risking breakthrough seizures.

Moderate Interactions (Monitor Closely)

  • Valproic acid: May increase levetiracetam levels, requiring observation for side effects.
  • Alcohol: Combined use can enhance central nervous system depression.
  • Other antiepileptic drugs: May require dose adjustments based on therapeutic monitoring.

Frequently Asked Questions

Levetiracetam Ratiopharm is used to treat epilepsy by reducing the frequency of partial seizures, generalized tonic‑clonic seizures, and myoclonic seizures. It helps stabilize neuronal activity and prevent seizure episodes in patients diagnosed with these seizure types.

Levetiracetam works by binding to the synaptic vesicle protein SV2A, which modulates the release of neurotransmitters. This action reduces calcium‑dependent exocytosis, decreasing neuronal excitability and limiting the synchronized firing that triggers epileptic seizures.

The appropriate dose of Levetiracetam Ratiopharm is individualized by the prescribing clinician based on factors such as the patient’s age, weight, renal function, seizure type, and response to therapy. No fixed dosing regimen is provided here.

Safety data for levetiracetam during pregnancy and lactation are limited. Healthcare providers should weigh potential benefits against risks and discuss options with the patient. Breastfeeding decisions should also be made in consultation with a medical professional.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam offers a distinct mechanism (SV2A modulation) and generally has fewer drug‑enzyme interactions than older agents such as carbamazepine or phenytoin. It is often preferred for its broad spectrum of seizure control and a relatively favorable side‑effect profile, though individual response varies.

Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original packaging to protect from moisture and light. Do not expose the product to excessive heat or humidity, and keep it out of reach of children.

Levetiracetam Ratiopharm is taken orally as a tablet. Patients should swallow the tablet whole with water, with or without food, as directed by their healthcare provider. Consistency in timing helps maintain stable blood levels.

Serious risks include severe allergic reactions (rash, swelling, breathing difficulty), significant mood changes such as depression or suicidal thoughts, and rare blood disorders like thrombocytopenia. Patients should seek immediate medical attention if any of these symptoms occur.

Individuals with a known hypersensitivity to levetiracetam or any component of the formulation should avoid the drug. Patients with severe renal impairment require dose adjustment; without proper adjustment, use may be contraindicated. Clinicians must evaluate each case before prescribing.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levetiracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT